2-((1-Acetyl-2-methylindoline)-5-sulfonamido)-N-(4-methoxyphenyl)-3-methylbutanamide

Catalog No. :
ACQZBQ132
CAS No. :
1093280-37-5
Molecular Formula :
C23H29N3O5S
Molecular Weight :
459.57

IUPAC Name:2-((1-acetyl-2-methylindoline)-5-sulfonamido)-N-(4-methoxyphenyl)-3-methylbutanamide

2-((1-Acetyl-2-methylindoline)-5-sulfonamido)-N-(4-methoxyphenyl)-3-methylbutanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((1-Acetyl-2-methylindoline)-5-sulfonamido)-N-(4-methoxyphenyl)-3-methylbutanamide
IUPAC Name2-((1-acetyl-2-methylindoline)-5-sulfonamido)-N-(4-methoxyphenyl)-3-methylbutanamide
Molecular FormulaC23H29N3O5S
Molecular Weight459.57
SMILESCC(C)C(NS(=O)(C1=CC2=C(N(C(C)=O)C(C)C2)C=C1)=O)C(NC3=CC=C(OC)C=C3)=O
InChI KeyYOYSYKZTDUYDQA-UHFFFAOYSA-N
SynonymButanamide, 2-[[(1-acetyl-2,3-dihydro-2-methyl-1H-indol-5-yl)sulfonyl]amino]-N-(4-methoxyphenyl)-3-methyl-
CAS No.1093280-37-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQZBQ132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQZBQ132 route product structure diagram
    ACQZBQ1321093280-37-5
Inquiry

2. ACQZBQ132 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQZBQ132 route product structure diagram
    ACQZBQ1321093280-37-5
Inquiry

Comments (0)